Order Article Reprints

Terpos E, Repousis P, Lalayanni C, Hatjiharissi E, Assimakopoulou T, Vassilopoulos G, Pouli A, Spanoudakis E, Michalis E, Pangalis G, et al. Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World “POWERFUL” Study. Journal of Clinical Medicine. 2021; 10(7):1509. https://doi.org/10.3390/jcm10071509

Terpos, Evangelos, Panagiotis Repousis, Chrysavgi Lalayanni, Evdoxia Hatjiharissi, Theodora Assimakopoulou, Georgios Vassilopoulos, Anastasia Pouli, Emmanouil Spanoudakis, Eurydiki Michalis, Gerassimos Pangalis, and et al. 2021. "Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World “POWERFUL” Study" Journal of Clinical Medicine 10, no. 7: 1509. https://doi.org/10.3390/jcm10071509

Terpos, E., Repousis, P., Lalayanni, C., Hatjiharissi, E., Assimakopoulou, T., Vassilopoulos, G., Pouli, A., Spanoudakis, E., Michalis, E., Pangalis, G., Ntanasis-Stathopoulos, I., Poziopoulos, C., Kyrtsonis, M.-C., Pappa, V., Symeonidis, A., Georgopoulos, C., Zikos, P. M., Gavriatopoulou, M., Papadaki, H. A., ... Katodritou, E. (2021). Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World “POWERFUL” Study. Journal of Clinical Medicine, 10(7), 1509. https://doi.org/10.3390/jcm10071509